Login / Signup

Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C.

Kazuhiko MishimaRyo NishikawaYoshitaka NaritaJunki MizusawaMinako SumiTomoyuki KogaNobuyoshi SasakiManabu KinoshitaMotoo NaganeYoshiki ArakawaKoji YoshimotoIchiyo ShibaharaNaoki ShinojimaKenichiro AsanoTakao TsurubuchiHikaru SasakiAkio AsaiTakashi SasayamaYasutomo MomiiAtsushi SasakiShigeo NakamuraMasaru KojimaJunichi TamaruKazuhiro TsuchiyaMiho GomyoKayoko AbeManabu NatsumedaFumiyuki YamasakiHiroshi KatayamaHaruhiko Fukuda
Published in: Neuro-oncology (2022)
This study failed to demonstrate the benefit of concomitant and maintenance TMZ in newly diagnosed PCNSL.
Keyphrases
  • newly diagnosed
  • phase iii
  • high dose
  • open label
  • clinical trial
  • double blind
  • placebo controlled
  • early stage
  • radiation therapy
  • randomized controlled trial
  • resting state
  • radiation induced
  • functional connectivity